RIL, Aurobindo Pharma, Britannia Industries to be watched

Image
Capital Market
Last Updated : Nov 09 2021 | 9:17 AM IST

Reliance Eagleford Upstream Holding, LP (REUHLP) a wholly owned step-down subsidiary of Reliance Industries (RIL), announced the signing of agreements with Ensign Operating III, LLC (Ensign), a Delaware limited liability company to divest its interest in certain upstream assets in the Eagleford shale play of Texas, USA. With this transaction, Reliance has divested all its shale gas assets and has exited from the shale gas business in North America.

Aurobindo Pharma reported 2.1% fall in consolidated net profit to Rs 696.70 crore on 2.1% fall in revenue from operations to Rs 5941.90 crore in Q2 FY22 over Q2 FY21.

Britannia Industries reported 22.9% fall in consolidated net profit to Rs 384.22 crore despite a 5.5% rise in total revenue from operations to Rs 3,607.37 crore in Q2 FY22 over Q2 FY21.

Zydus Cadila has received an order to supply one crore doses of ZyCoV-D, the world's first Plasmid DNA Vaccine, to the Government of India at Rs. 265 per dose and the needle-free applicator being offered at Rs. 93 per dose, excluding GST.

National Aluminium Company said that the meeting of the board of directors of the company scheduled to be held on 12th November 2021 to consider interim dividend, if any, for the financial year 2021-22.

Route Mobile said the company has launched its Qualified Institutions Placement (QIP) issue of equity shares to qualified institutional buyers on Monday and approved the floor price of Rs 1,949.24 per share.

FDC has received Good Manufacturing Practice (GMP) certificate. It continues with its approved status from UK MHRA (Medicines and Healthcare Products Regulatory Agency), for the Ophthalmic facility located at Waluj, Aurangabad, Maharashtra, based on the recent GMP inspection held remotely between 06th to 09th September, 2021.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 09 2021 | 8:34 AM IST

Next Story